MetaCap

Doximity Inc. Class A (DOCS)

NYSE: DOCSTechnologyEDP ServicesUSD

27.69-0.10 (-0.36%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

DOCS stock chart

Technical analysis

Key statistics

All statistics
52-week range
17.15 – 73.92
Day range
27.52 – 28.28
Volume / Avg
2.39M / 4.40M
Beta
—
Next earnings
Nov 5, 2026

52-week range

$17.15$73.92

DOCS stock today

Doximity (DOCS) closed at $27.69 on Oct 7, down 0.36% (-$0.10), versus the S&P 500's 0.22% decline. Shares are 62.5% below their 52-week high of $73.92, set on Oct 8, 2025 and 61.5% above the 52-week low of $17.15, near the bottom of the past year's range. DOCS is down 37.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 61.2%.

At 32.6x trailing earnings, Doximity trades above the peer-group median of 17.1x. Its forward P/E of 17.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Doximity's next earnings report is expected on Nov 5, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Doximity

Company profile

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems.

Industry
EDP Services
CEO
Mr. Jeffrey A. Tangney
Headquarters
San Francisco, CA
Employees
880
IPO year
2021

Financial highlights

Full financials

In fiscal 2026, Doximity generated $644.9 million in revenue, up 13.1% from fiscal 2025, its 6th consecutive year of revenue growth. Net income was $196.1 million (-12.2% year over year), for a net margin of 30.4% versus a median of 31.0% in the prior 5 years. Gross margin was 89.1% (down from 90.2%) and operating margin 33.3%.

Doximity annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$644.86M$570.40M$475.42M$419.05M$343.55M
Growth+13.05%+19.98%+13.45%+21.98%+66.05%
Net income$196.05M$223.19M$147.58M$112.82M$154.78M
EPS (diluted)$0.98$1.11$0.72$0.53$0.70

Analyst forecast

Forecast

Consensus (21 analysts)

hold

Avg. price target

$29.67+7.15%

  • Strong buy 5
  • Buy 3
  • Hold 11
  • Sell 1
  • Strong sell 1

Target range

Low $18.00High $47.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Nov 5, 2026
EPS estimate
$0.19
Last reported (Q1 2027)
Aug 6, 2026
EPS actual vs est.
$0.13 vs —

Doximity peers

Technology sector
DOCS peer companies
CompanyPrice% ChgMarket capCompare
WAYWaystar Holding Corp.25.77-2.39%$4.94Bvs DOCS
RGTIRigetti Computing Inc.14.59-3.82%$4.87Bvs DOCS
SAICScience Applications International Corporation122.08-2.01%$5.11Bvs DOCS
PSNParsons Corporation42.02-0.19%$4.49Bvs DOCS
EPAMEPAM Systems Inc.108.32-0.91%$5.59Bvs DOCS
OTEXOpen Text Corporation23.14+1.89%$5.62Bvs DOCS
PEGAPegasystems Inc.34.35-0.72%$5.65Bvs DOCS
QBTSD-Wave Quantum Inc.15.22-3.61%$5.78Bvs DOCS

Indexes, lists and sector

Doximity stock FAQ

What is Doximity's stock price today?

DOCS last traded at $27.69 as of Oct 7, 4:00 PM EDT, down 0.36% on the day. Prices are delayed at least 15 minutes.

When is Doximity's next earnings date?

Doximity is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.19.

What is DOCS's P/E ratio?

DOCS trades at a trailing P/E ratio of 32.58 and a forward P/E of 17.78, compared with a median of 17.1 for its closest peers.

Who is Doximity's CEO?

Mr. Jeffrey A. Tangney is the chief executive officer of Doximity Inc. Class A, which has about 880 employees.

What is the DOCS 52-week high?

The 52-week high for DOCS is $73.92 and the 52-week low is $17.15. The stock is currently 62.5% below its high.

Compare DOCS